Bright Minds Biosciences (DRUG) - 2023 Q1 - Quarterly Report

Bright Minds Biosciences Inc. Condensed Interim Consolidated Financial Statements For the three months ended December 31, 2022 and 2021 (Expressed in Canadian Dollars) 1 | Page Bright Minds Biosciences Inc. Condensed Interim Consolidated Statements of Financial Position The accompanying notes are an integral part of these condensed interim consolidated financial statements. 2 | Page Bright Minds Biosciences Inc. Condensed Interim Consolidated Statements of Comprehensive Loss (Expressed in Canadian dollars - ...